What do patients with metastatic bone pain need?

European Journal of Cancer, Supplement

Volumn 4, Issue 8, 2006, Pages 1-3

  Diel, Ingo J ^a  

^a CGG Klinik GmbH   (Germany)

Author keywords

Bisphosphonate; Bone metastases; Cancer; Ibandronate; Metastatic bone pain

Indexed keywords

ANALGESIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; IBANDRONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PAMIDRONIC ACID; ZOLEDRONIC ACID;

ANALGESIA; ARTICLE; BONE DISEASE; BONE MARROW SUPPRESSION; BONE METASTASIS; BONE PAIN; BREAST CANCER; CANCER PAIN; CANCER PATIENT; CANCER RADIOTHERAPY; CAREGIVER BURDEN; COGNITIVE DEFECT; CONSTIPATION; DAILY LIFE ACTIVITY; DIARRHEA; DROWSINESS; GASTROINTESTINAL TOXICITY; HUMAN; HYPERCALCEMIA; IRRADIATION; NAUSEA; NEPHROTOXICITY; ONCOLOGY; PAIN ASSESSMENT; PALLIATIVE THERAPY; PATHOLOGIC FRACTURE; PATIENT ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SPINAL CORD COMPRESSION; VOMITING;

EID: 33747605783     PISSN: 13596349     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcsup.2006.07.001     Document Type: Article

References (34)

1. Coleman R.E. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27 3 (2001) 165-176
2. Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain 69 1-2 (1997) 1-18
3. Saarto T., Janes R., Tenhunen M., and Kouri M. Palliative radiotherapy in the treatment of skeletal metastases. Eur J Pain 6 5 (2002) 323-330
4. Solomayer E.F., Diel I.J., Meyberg G.C., Gollan C., and Bastert G. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59 3 (2000) 271-278
5. Janjan N.A., Payne R., Gillis T., et al. Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases. J Pain Symptom Manage 16 3 (1998) 171-178
6. Cleeland C.S., Gonin R., Hatfield A.K., et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330 9 (1994) 592-596
7. Portenoy R.K., Payne D., and Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 81 1-2 (1999) 129-134
8. Mercadante S., Radbruch L., Caraceni A., et al. Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer 94 3 (2002) 832-839
9. Mercadante S., and Arcuri E. Breakthrough pain in cancer patients: pathophysiology and treatment. Cancer Treat Rev 24 6 (1998) 425-432
10. Zeppetella G., O'Doherty C.A., and Collins S. Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Symptom Manage 20 2 (2000) 87-92
11. Petzke F., Radbruch L., Zech D., Loick G., and Grond S. Temporal presentation of chronic cancer pain: transitory pains on admission to a multidisciplinary pain clinic. J Pain Symptom Manage 17 6 (1999) 391-401
12. Caraceni A., Martini C., Zecca E., et al. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat Med 18 3 (2004) 177-183
13. Mustchin E, Valentini M. Communication barriers delay effective treatment of metastatic bone pain: European market research results. Presentation at the 31st European Society for Medical Oncology congress, Istanbul, Turkey. [Abstract 929P].
14. McParland C., and Grosjean L. Treatment of painful bone metastases in Europe and Canada: the role of bisphosphonates. Ann Oncol 15 Suppl. 3 (2004) iii50 [Abstract 190P]
15. Johnson G., Gralow J., and Benson P. Use of bisphosphonates for the palliative care of metastatic bone pain: US market research results. Ann Oncol 15 Suppl. 3 (2004) iii224 [Abstract 849P]
16. Cleeland C.S., Janjan N.A., Scott C.B., Seiferheld W.F., and Curran W.J. Cancer pain management by radiotherapists: a survey of radiation therapy oncology group physicians. Int J Radiat Oncol Biol Phys 47 1 (2000) 203-208
17. Larue F., Colleau S.M., Brasseur L., and Cleeland C.S. Multicentre study of cancer pain and its treatment in France. BMJ 310 6986 (1995) 1034-1037
18. Cherny N., Ripamonti C., Pereira J., et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19 9 (2001) 2542-2554
19. McNicol E., Horowicz-Mehler N., Fisk R.A., et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 4 5 (2003) 231-256
20. McNicol E., Strassels S.A., Goudas L., Lau J., and Carr D.B. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database Syst Rev 1 (2005) CD005180
21. Sze W.M., Shelley M., Held I., and Mason M. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy. Cochrane Database Syst Rev 1 (2003) CD004721
22. Wu J.S., Wong R., Johnston M., Bezjak A., and Whelan T. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55 3 (2003) 594-605
23. Tong D., Gillick L., and Hendrickson F.R. The palliation of symptomatic osseous metastases: final results of the study by the Radiation Therapy Oncology Group. Cancer 50 5 (1982) 893-899
24. Falkmer U., Jarhult J., Wersall P., and Cavallin-Stahl E. A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncol 42 5-6 (2003) 620-633
25. Finlay I.G., Mason M.D., and Shelley M. Radioisotopes for the palliation of metastatic bone cancer: a systematic review. Lancet Oncol 6 6 (2005) 392-400
26. Pandit-Taskar N., Batraki M., and Divgi C.R. Radiopharmaceutical therapy for palliation of bone pain from osseous metastases. J Nucl Med 45 8 (2004) 1358-1365
27. Coleman R.E. Bisphosphonates: clinical experience. Oncologist 9 Suppl. 4 (2004) 14-27
28. Rogers M.J., Gordon S., Benford H.L., et al. Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88 12 Suppl. (2000) 2961-2978
29. Wong R., and Wiffen P.J. Bisphosphonates for the relief of pain secondary to bone metastases. Cochrane Database Syst Rev 2 (2002) CD002068
30. Rosen L.S., Gordon D., Kaminski M., et al. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer 98 8 (2003) 1735-1744
31. McCormack P.L., and Plosker G.L. Ibandronic acid: a review of its use in the treatment of bone metastases of breast cancer. Drugs 66 5 (2006) 711-728
32. Diel I.J. Ibandronate: efficacy in the treatment of metastatic bone disease. Future Oncol 1 5 (2005) 593-607
33. Krempien R., Niethammer A., Harms W., and Debus J. Bisphosphonates and bone metastases: current status and future directions. Expert Rev Anticancer Ther 5 2 (2005) 295-305
34. Body J.J., Diel I., and Bell R. Profiling the safety and tolerability of bisphosphonates. Semin Oncol 31 5 Suppl. 10 (2004) 73-78